DSP Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1208 Cr | ₹3138 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹100 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 28 Dec 2015 | 30 Nov 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | Nifty Pharma TRI | BSE Healthcare |
| Turn Over | 26.49% | 18% |
| Expense Ratio | 2.14 | 1.92 |
| Manager | Meeta Shetty | Jay Kothari |
| ISIN Code | INF277K016A9 | INF740KA1LD8 |
| Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Month | 3.55% | -0.6% |
| 6 Month | 18.35% | 24.19% |
| 1 Year | 40% | 39.82% |
| 3 Year | 21.88% | 21.68% |
| 5 Year | 27.51% | 30.65% |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 31.82% | 35.07% |
| 3 Year | 32.32% | 33.82% |
| 5 Year | 25.8% | 27.43% |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| 1 Year | 6.67% | 27.85% |
| 3 Year | 17.46% | 20.38% |
| 5 Year | 14.22% | 27.14% |
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Standard Deviation | 14.23% | 14.69% |
| Sharp | 0.74% | 0.76% |
| Beta | 0.9% | 0.93% |
| Alpha | 2.85% | 3.36% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Name | Meeta Shetty | Jay Kothari |
| Total AUM | ₹17847 Cr | ₹0 Cr |
| Fund Manage | 5 | 20 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | DSP Healthcare Fund - Regular Plan - Growth |
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 5.39 | 17.61 |
| Small Cap | 23.46 | 41.87 |
| Large Cap | 40.33 | 22.07 |
| Mid Cap | 30.82 | 18.45 |
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
DSP Healthcare Fund - Regular Plan - Growth |
|---|---|---|
| Others | 5.39 | 17.61 |
| Pharmaceuticals & Biotechnology | 76.28 | 68.54 |
| Healthcare Services | 14.31 | 11.97 |
| Fertilizers & Agrochemicals | 0.83 | - |
| Chemicals & Petrochemicals | 0.39 | - |
| Insurance | 2.14 | 1.47 |
| Retailing | 0.66 | 0.41 |
Top Comparisons
Sundaram Aggressive Hybrid Fund (Formerly Known as Principal Hybrid Equity Fund)-Growth
3Y Returns12.54%
Quant Absolute Fund-Growth
3Y Returns13.33%
HDFC Hybrid Debt Fund - Growth Plan
3Y Returns10.26%
Canara Robeco Conservative Hybrid Fund - Regular Plan - Growth Option
3Y Returns7.63%
Edelweiss Overnight Fund - Regular Plan - Growth
3Y Returns5.9%
Baroda BNP Paribas Overnight Fund - Regular Plan - Growth
3Y Returns5.94%
Kotak Nifty Next 50 Index Fund - Regular Plan - Growth Option
3Y Returns18.48%
Motilal Oswal Nifty Next 50 Index Fund - Regular plan - Growth
3Y Returns18.06%